Page 1 of 185
NUR 641E MIDTERM STUDY GUIDE
ADVANCED PATHOPHYSIOLOGY AND
PHARMACOLOGY FOR THE NURSE
EDUCATOR
2026-2027 ACADEMIC YEAR |
COMPREHENSIVE PRACTICE QUESTION
BANK
## SECTION I: PHARMACOKINETICS
### Question 1
A nurse educator is teaching a group of nursing students about the basic principles of
pharmacokinetics. Which statement accurately describes the scope of pharmacokinetics?
A. The study of drug-receptor interactions and the physiological effects of drugs on the body
B. The process by which drugs are absorbed, distributed, metabolized, and eliminated by the
body
C. The study of drug toxicity, adverse effects, and overdose management
D. The process of drug manufacturing, formulation, and quality control
**Correct Answer: B**
,Page 2 of 185
**Rationale:** Pharmacokinetics is defined as what the body does to the drug and encompasses
the four processes of ADME: absorption (movement from administration site into bloodstream),
distribution (movement from bloodstream to tissues), metabolism (biotransformation of the
drug), and elimination (removal of the drug and metabolites from the body). Option A describes
pharmacodynamics, which is what the drug does to the body. Option C describes toxicology, and
Option D describes pharmaceutical manufacturing.
---
### Question 2
Which route of drug administration provides the highest bioavailability and why?
A. Oral, because it allows for gradual absorption through the gastrointestinal tract
B. Intramuscular, because muscle tissue has extensive blood supply
C. Intravenous, because it places the entire dose directly into the bloodstream, bypassing
absorption and first-pass metabolism
D. Sublingual, because it avoids gastrointestinal degradation
**Correct Answer: C**
**Rationale:** The intravenous (IV) route provides 100% bioavailability because the entire dose
is delivered directly into the systemic circulation, completely bypassing the absorption phase and
first-pass metabolism in the liver. Oral administration is subject to variable absorption and first-
pass metabolism. Intramuscular and sublingual routes have good bioavailability but are still
subject to absorption barriers and cannot match the complete bioavailability of IV administration.
---
### Question 3
A patient has been taking a medication with a half-life of 6 hours. Approximately how long will
it take for this drug to reach steady-state concentration?
,Page 3 of 185
A. 6-12 hours
B. 12-18 hours
C. 24-30 hours
D. 36-42 hours
**Correct Answer: C**
**Rationale:** Steady-state concentration is typically reached after approximately 4-5 half-lives
of a drug. With a half-life of 6 hours, 4-5 half-lives would be 24-30 hours (6 hours × 4 = 24
hours; 6 hours × 5 = 30 hours). At steady state, the rate of drug administration equals the rate of
elimination, and plasma concentrations remain relatively constant with each dose.
---
### Question 4
A nurse is caring for a patient receiving a drug with a narrow therapeutic index. Which of the
following statements best describes the clinical significance of a narrow therapeutic index?
A. The drug has a wide margin of safety and is unlikely to cause toxicity
B. The difference between the therapeutic dose and toxic dose is small, requiring careful
monitoring
C. The drug is effective only at very high doses
D. The drug is completely eliminated from the body within one half-life
**Correct Answer: B**
**Rationale:** The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose
(TD₅₀/ED₅₀). A narrow therapeutic index means there is a small margin between the dose that
, Page 4 of 185
produces therapeutic effects and the dose that causes toxicity. Drugs with narrow therapeutic
indices (e.g., warfarin, digoxin, phenytoin) require careful therapeutic drug monitoring to
maintain levels within the therapeutic range and avoid adverse effects.
---
### Question 5
Which of the following factors does NOT affect the bioavailability of a drug?
A. First-pass metabolism
B. Chemical stability of the drug
C. The drug's mechanism of action
D. Solubility of the drug
**Correct Answer: C**
**Rationale:** Bioavailability is affected by chemical stability, solubility, and first-pass
metabolism. The mechanism of action (how the drug produces its therapeutic effect) does not
affect bioavailability; it is a pharmacodynamic property. Bioavailability refers to the rate and
extent to which an active drug is absorbed and reaches systemic circulation.
---
### Question 6
A drug that is a prodrug requires which of the following to become therapeutically active?
A. Binding to plasma proteins
B. Biotransformation through biochemical reactions, often involving cytochrome P450 enzymes
C. Excretion through the kidneys
NUR 641E MIDTERM STUDY GUIDE
ADVANCED PATHOPHYSIOLOGY AND
PHARMACOLOGY FOR THE NURSE
EDUCATOR
2026-2027 ACADEMIC YEAR |
COMPREHENSIVE PRACTICE QUESTION
BANK
## SECTION I: PHARMACOKINETICS
### Question 1
A nurse educator is teaching a group of nursing students about the basic principles of
pharmacokinetics. Which statement accurately describes the scope of pharmacokinetics?
A. The study of drug-receptor interactions and the physiological effects of drugs on the body
B. The process by which drugs are absorbed, distributed, metabolized, and eliminated by the
body
C. The study of drug toxicity, adverse effects, and overdose management
D. The process of drug manufacturing, formulation, and quality control
**Correct Answer: B**
,Page 2 of 185
**Rationale:** Pharmacokinetics is defined as what the body does to the drug and encompasses
the four processes of ADME: absorption (movement from administration site into bloodstream),
distribution (movement from bloodstream to tissues), metabolism (biotransformation of the
drug), and elimination (removal of the drug and metabolites from the body). Option A describes
pharmacodynamics, which is what the drug does to the body. Option C describes toxicology, and
Option D describes pharmaceutical manufacturing.
---
### Question 2
Which route of drug administration provides the highest bioavailability and why?
A. Oral, because it allows for gradual absorption through the gastrointestinal tract
B. Intramuscular, because muscle tissue has extensive blood supply
C. Intravenous, because it places the entire dose directly into the bloodstream, bypassing
absorption and first-pass metabolism
D. Sublingual, because it avoids gastrointestinal degradation
**Correct Answer: C**
**Rationale:** The intravenous (IV) route provides 100% bioavailability because the entire dose
is delivered directly into the systemic circulation, completely bypassing the absorption phase and
first-pass metabolism in the liver. Oral administration is subject to variable absorption and first-
pass metabolism. Intramuscular and sublingual routes have good bioavailability but are still
subject to absorption barriers and cannot match the complete bioavailability of IV administration.
---
### Question 3
A patient has been taking a medication with a half-life of 6 hours. Approximately how long will
it take for this drug to reach steady-state concentration?
,Page 3 of 185
A. 6-12 hours
B. 12-18 hours
C. 24-30 hours
D. 36-42 hours
**Correct Answer: C**
**Rationale:** Steady-state concentration is typically reached after approximately 4-5 half-lives
of a drug. With a half-life of 6 hours, 4-5 half-lives would be 24-30 hours (6 hours × 4 = 24
hours; 6 hours × 5 = 30 hours). At steady state, the rate of drug administration equals the rate of
elimination, and plasma concentrations remain relatively constant with each dose.
---
### Question 4
A nurse is caring for a patient receiving a drug with a narrow therapeutic index. Which of the
following statements best describes the clinical significance of a narrow therapeutic index?
A. The drug has a wide margin of safety and is unlikely to cause toxicity
B. The difference between the therapeutic dose and toxic dose is small, requiring careful
monitoring
C. The drug is effective only at very high doses
D. The drug is completely eliminated from the body within one half-life
**Correct Answer: B**
**Rationale:** The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose
(TD₅₀/ED₅₀). A narrow therapeutic index means there is a small margin between the dose that
, Page 4 of 185
produces therapeutic effects and the dose that causes toxicity. Drugs with narrow therapeutic
indices (e.g., warfarin, digoxin, phenytoin) require careful therapeutic drug monitoring to
maintain levels within the therapeutic range and avoid adverse effects.
---
### Question 5
Which of the following factors does NOT affect the bioavailability of a drug?
A. First-pass metabolism
B. Chemical stability of the drug
C. The drug's mechanism of action
D. Solubility of the drug
**Correct Answer: C**
**Rationale:** Bioavailability is affected by chemical stability, solubility, and first-pass
metabolism. The mechanism of action (how the drug produces its therapeutic effect) does not
affect bioavailability; it is a pharmacodynamic property. Bioavailability refers to the rate and
extent to which an active drug is absorbed and reaches systemic circulation.
---
### Question 6
A drug that is a prodrug requires which of the following to become therapeutically active?
A. Binding to plasma proteins
B. Biotransformation through biochemical reactions, often involving cytochrome P450 enzymes
C. Excretion through the kidneys
